ArticleCancers2022

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.